Cancer, Bladder Active Not Recruiting Phase 2 Trials for Cisplatin (DB00515)

Also known as: Bladder Cancers / Bladder Cancer / Malignant neoplasm of urinary bladder NOS / Bladder neoplasms malignant / Malignant neoplasm of bladder / Urinary Bladder Cancer / Malignant neoplasm of bladder, part unspecified / Bladder cancer NOS / Ca bladder

IndicationStatusPhase
DBCOND0092003 (Cancer, Bladder)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02177695S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder CancerTreatment
NCT00082706Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal RemnantTreatment
NCT02951767A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1)Treatment
NCT00981656Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder CancerTreatment
NCT00777491Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by SurgeryTreatment